PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Vasaka tea protected airway epithelial cells from wood smoke particle-induced damage and prevented pathological mucus production by inhibiting TRPA1 and ER stress [PMID:37375837]
Green synthesized silver nanoparticles using Justicia adhatoda leaf extract demonstrated antibacterial activity against Pseudomonas aeruginosa MTCC 741 [PMID:25805902]
The leaf extract was evaluated for its effect on coagulation profiles in mice (induced by warfarin, aspirin, and dabigatran) and in-vitro platelet aggregation of human blood [PMID:33774945]
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 25805902 (2015) — Antibacterial Activity of Green Synthesized Silver Nanoparticles Using Vasaka (Justicia adhatoda L.) Leaf Extract. · Indian journal of microbiology
- 2.PMID: 38379997 (2024) — Exploring the pharmacological and chemical aspects of pyrrolo-quinazoline derivatives in Adhatoda vasica. · Heliyon
- 3.PMID: 37375837 (2023) — Inhibition of TRPA1, Endoplasmic Reticulum Stress, Human Airway Epithelial Cell Damage, and Ectopic MUC5AC Expression by Vasaka (Adhatoda vasica; Malabar Nut) Tea. · Pharmaceuticals (Basel, Switzerland)
- 4.PMID: 29747746 (2018) — Justicia adhatoda induces megakaryocyte differentiation through mitochondrial ROS generation. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 5.PMID: 33774945